The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Pathophysiology and Current Clinical Management of Preeclampsia
Open accessAbstract
Preeclampsia is characterized by blood pressure greater than 140/90 mmHg in the second half of pregnancy. This disease is a major contributor to preterm and low birth weight babies. The early delivery of the baby, which becomes necessary for maintaining maternal well-being, makes preeclampsia the leading cause for preterm labor and infant mortality and morbidity. Currently, there is no cure for this pregnancy disorder. The current clinical management of PE is hydralazine with labetalol and magnesium sulfate to slow disease progression and prevent maternal seizure, and hopefully prolong the pregnancy. This review will highlight factors implicated in the pathophysiology of preeclampsia and current treatments for the management of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
WHO analysis of causes of maternal death: a systematic review
Khan, K. S., Wojdyla, D., Say, L., Gülmezoglu, A. M., & Van Look, P. F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68397-9 · Cited by 3,978 · cited 1×
“Abbreviations: TH1 T helper cells type 1, TH2T helper cells type 2,AT1-AA autoantibodies to angiotensin II type 1 receptor, ET-1 endothelin 1, sFlt-1 soluble vascular endothelial growth factor receptor 1, NO nitric oxide, IUGR uterine growth restriction 61 Page 2 of 6 Curr Hypertens Rep (2017) 19: 61”
(2013) · doi:10.1097/01.aog.0000437382.03963.88 · Cited by 3,961
The Global Impact of Pre-eclampsia and Eclampsia
Duley, L. (2009) · Seminars in Perinatology · doi:10.1053/j.semperi.2009.02.010 · Cited by 2,866
Latest Advances in Understanding Preeclampsia
Redman, C. W., & Sargent, I. L. (2005) · Science · doi:10.1126/science.1111726 · Cited by 2,607
Onuegbu, A. J., Olisekodiaka, J. M., Udo, J. U., Umeononihu, O., Amah, U. K., Okwara, J. E., & Atuegbu, C. (2015) · Medical Principles and Practice · doi:10.1159/000381778 · Cited by 2,044
Bartsch, E., Medcalf, K. E., Park, A. L., & Ray, J. G. (2016) · BMJ · doi:10.1136/bmj.i1753 · Cited by 996
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor
Wallukat, G., Homuth, V., Fischer, T., Lindschau, C., Horstkamp, B., Jüpner, A., Baur, E., Nissen, E., Vetter, K., Neichel, D., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4106 · Cited by 826
Roberts, J. M., & Gammill, H. S. (2005) · Hypertension · doi:10.1161/01.hyp.0000188408.49896.c5 · Cited by 693
REVIEW ARTICLE: Immunology of Pre‐Eclampsia
Redman, C. W. G., & Sargent, I. L. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00831.x · Cited by 672
Cited by
Stepan, H., Galindo, A., Hund, M., Schlembach, D., Sillman, J., Surbek, D., & Vatish, M. (2023) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.26032 · Cited by 245
Metadata
- Authors
- Amaral, L. M., Wallace, K., Owens, M., & LaMarca, B.
- Venue
- Current Hypertension Reports
- Published
- 2017-07-08
- Volume
- 19
- Issue
- 8
- Pages
- 61-61
- ISSN
- 1522-6417 (ISSN-L)
- 1534-3111
- OpenAlex
- W2727740730
- Cited by
- 276
- References
- 62
- FWCI
- 18.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathophysiology and Current Clinical Management of Preeclampsia. https://app.cochat.ai/papers/10.1007/s11906-017-0757-7
- The paper
- Amaral, L. M., Wallace, K., Owens, M., & LaMarca, B. (2017). Pathophysiology and Current Clinical Management of Preeclampsia. Current Hypertension Reports. https://doi.org/10.1007/s11906-017-0757-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.